111 – 120 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
- Contribution to journal › Article
-
Mark
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
- Contribution to journal › Article
-
Mark
Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients
- Contribution to journal › Article
-
Mark
Stromal progesterone receptor expression and long-term survival in patients with resected periampullary adenocarcinoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.262-263
- Contribution to journal › Published meeting abstract
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.180-180
- Contribution to journal › Published meeting abstract
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.463-463
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.220-220
- Contribution to journal › Published meeting abstract
-
Mark
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
(2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.65-65
- Contribution to journal › Published meeting abstract
-
Mark
A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk
(2018) In Clinical cancer research : an official journal of the American Association for Cancer Research 24(23). p.5895-5901
- Contribution to journal › Article
- 2017
-
Mark
Prognostic value of HER3 and HER2 alterations in colorectal cancer: Relationship with sidedness, KRAS and BRAF mutation status
(2017) European Society of Medical Oncologys annual congress
- Contribution to conference › Abstract
